PATENT AND TECHNOLOGY LICENSE AGREEMENTConfidential Treatment • March 31st, 2006 • Callisto Pharmaceuticals Inc • Pharmaceutical preparations • Texas
This twenty-seven (27) page AGREEMENT ("AGREEMENT") is made on this 10th day of January 2006, by and between THE BOARD OF REGENTS ("BOARD") of THE UNIVERSITY OF TEXAS SYSTEM ("SYSTEM"), an agency of the State of Texas, whose address is 201 West 7th Street, Austin, Texas 78701, on behalf of THE UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER ("UTMDACC"), a component institution of SYSTEM, and CALLISTO PHARMACEUTICALS, INC., a Delaware corporation having a principal place of business located at 420 Lexington Avenue, Suite 1609, New York, New York 10170 (“LICENSEE”).
